Brenig Therapeutics
Brain-penetrant small-molecule inhibitors targeting LRRK2 and NLRP3 for Parkinson's disease
- Sector
- Biotech
- Headquarters
- DOVER, DE
- Founded
- 2021
- Latest Form D
- $30M, Jul 2024
- Total capital
- $30M
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- $30M
- 1 Form D · last Jul 2024
- 27 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 0
- 5 pending
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 1st filing$30M
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Founders and team
From SEC Form D filings- Edward MathersDirectorNamed in SEC Form D filings
- Iain DukesExecutive Officer, DirectorNamed in SEC Form D filings
- Keno GutierrezDirectorNamed in SEC Form D filings
- Michele CuculluDirectorNamed in SEC Form D filings
- Nikolay SavchukExecutive Officer, DirectorNamed in SEC Form D filings
What it has protected
USPTO · 0 granted of 5- PendingLRRK2 InhibitorsUSPTOApplication 18854031
- PendingLRRK2 InhibitorsUSPTOApplication PCTUS2025028256
- PendingLRRK2 InhibitorsUSPTOApplication 63644490
Show all 5 patent records
- LRRK2 InhibitorsAug 7, 2025 · Application 18854031Pending
- LRRK2 InhibitorsApplication PCTUS2025028256Pending
- LRRK2 InhibitorsApplication 63644490Pending
- LRRK2 InhibitorsApplication PCTUS2023063745Pending
- LRRK2 InhibitorsApplication 63327058Pending
Related companies, and why
- SymbioCellTech, LLCSimilar federal contract value in Biotech · null in contracts
- Marea TherapeuticsSimilar federal contract value in Biotech · null in contracts
- Belenos Biosciences, Inc.Similar federal contract value in Biotech · null in contracts
- Cadenza Bio, Inc.Similar federal contract value in Biotech · null in contracts
- Clearmind Medicine Inc.Similar federal contract value in Biotech · null in contracts
- Pep2Tango Therapeutics, Inc.Similar federal contract value in Biotech · null in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .